AbbVie Profit Margins 2010-2018 | ABBV

Current and historical gross, operating and net profit margins for AbbVie (ABBV) over the last 10 years. The current net profit margin for AbbVie (ABBV) as of March 31, 2018 is 21.55%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.940B $28.216B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.858B 16.72
Pfizer (PFE) United States $223.411B 13.75
Novartis AG (NVS) Switzerland $182.569B 15.82
Merck (MRK) United States $169.563B 15.15
Novo Nordisk (NVO) Denmark $121.883B 20.19
Sanofi (SNY) France $105.164B 13.31
GlaxoSmithKline (GSK) United Kingdom $103.492B 14.15
Eli Lilly (LLY) United States $97.374B 19.33
AstraZeneca (AZN) United Kingdom $94.122B 9.86
Bristol-Myers Squibb (BMY) United States $92.940B 18.28